Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02968940
Title Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors New York University School of Medicine
Indications

high grade glioma

glioblastoma

Therapies

Avelumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST